Literature DB >> 11344739

Feeding tolerance of ready-to-use versus powdered formulas in neonates.

M Weisbrod1, F B Mimouni.   

Abstract

BACKGROUND: Following the introduction of ready-to-use formula in our neonatal department, we observed an increase in the number of neonates regurgitating after feeding.
OBJECTIVE: To compare the feeding tolerance of neonates, in terms of regurgitations, to ready-to-use versus powdered formulas.
METHODS: We compared the number of regurgitations in 727 healthy neonates after feeding ready-to-use formulas and powdered formulas of two different manufacturers. Six groups of neonates were formed, three for each manufacturer. Each of the two groups was fed with either ready-to-use formula or with reconstructed powdered formula (using a two-compartment patented feeding bottle called Twist 'N Feed) and one group received both preparations during 2 successive days.
RESULTS: The groups that were fed only with ready-to-use formulas had significantly more regurgitations than those fed with powdered formulas. Within the group that received both types of formulas there were significantly more regurgitations following the ready-to-use than the powdered formula.
CONCLUSIONS: Feeding tolerance, in terms of regurgitations, was significantly better in neonates fed reconstituted powdered formula as opposed to ready-to-use formulas. More studies are required to determine the exact mechanism for these differences.

Mesh:

Substances:

Year:  2000        PMID: 11344739

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  2 in total

1.  Feeding intolerance in preterm infants fed with powdered or liquid formula: a randomized controlled, double-blind, pilot study.

Authors:  Ozge Surmeli-Onay; Ayse Korkmaz; Sule Yigit; Murat Yurdakok
Journal:  Eur J Pediatr       Date:  2013-01-05       Impact factor: 3.183

2.  Feeding Intolerance in Preterm Infants Fed with Powdered or Liquid Formula: A Randomized Controlled, Double-blind Pilot Study.

Authors:  Lena Ignacio; Khalid Alfaleh
Journal:  J Clin Neonatol       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.